# FDA Inspection 1268696 - Yancheng Suhai Pharmaceutical Co., Ltd. - April 17, 2025

Source: https://www.keypedia.com/records/fda_inspections/yancheng-suhai-pharmaceutical-co-ltd/371e15a3-707f-45bb-9710-a589293dacc5
Source feed: FDA_Inspections

> FDA Inspection 1268696 for Yancheng Suhai Pharmaceutical Co., Ltd. on April 17, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1268696
- Company Name: Yancheng Suhai Pharmaceutical Co., Ltd.
- Inspection Date: 2025-04-17
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1268696 - 2025-04-17](https://www.keypedia.com/records/fda_inspections/yancheng-suhai-pharmaceutical-co-ltd/e94dc3a9-58a2-46bf-9cf3-3d92336957c5)
- [FDA Inspection 1091663 - 2019-04-26](https://www.keypedia.com/records/fda_inspections/yancheng-suhai-pharmaceutical-co-ltd/ce56b642-58e4-498f-bfc5-220cbe67ff0a)
- [FDA Inspection 923773 - 2015-03-13](https://www.keypedia.com/records/fda_inspections/yancheng-suhai-pharmaceutical-co-ltd/a8b78746-4a55-4fba-995f-fd0b0cac72a9)

Company: https://www.keypedia.com/companies/yancheng-suhai-pharmaceutical-co-ltd/1856530d-8073-4ddc-8def-1ecdf4f9bd0c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c